, Tracking Stock Market Picks
Enter Symbol:
Catalyst Pharmaceutical Partners, Inc. (CPRX) [hlAlert]

down 53.88 %

Catalyst Pharmaceutical Partners, Inc. (CPRX) downgraded to Sell by Merriman Curhan Ford

Posted on: Friday,  May 29, 2009  10:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Sell Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) on 05/29/2009. Previously Merriman Curhan Ford rated Buy Catalyst Pharmaceutical Partners, Inc. (NASDAQ:
CPRX) on 12/15/2008., when the stock price was $2.06. Since then, Catalyst Pharmaceutical Partners, Inc. has lost 53.88% as of 05/29/2009's recent price of $0.95.
If you would have followed the previous Merriman Curhan Ford's recommendation on CPRX, you would have lost 53.88% of your investment in 165 days.

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. Its product candidate CPP-109, which is the version of the chemical compound gamma-vinyl-GABA, referred to as vigabatrin. As of December 31, 2008, the Company was conducting two clinical trials of CPP-109, one evaluating its use in the treatment of cocaine addiction, and a second evaluating its use in the treatment of methamphetamine addiction. CPP-109 has the potential to treat other addictions, including addictions to nicotine, prescription pain, medications, alcohol, and marijuana, as well as obsessive-compulsive disorders, such as obesity and compulsive gambling.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/29/2009 10:25 AM Sell
as of 12/31/2009
1 Week down  -82.53 %
1 Month down  -49.35 %
3 Months down  -36.90 %
1 YTD down  -68.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2008 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy